Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cenk Ayata, M.D.

Co-Author

This page shows the publications co-authored by Cenk Ayata and Katharina Eikermann-Haerter.
Connection Strength

7.807
  1. Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice. Ann Neurol. 2015 Aug; 78(2):193-210.
    View in: PubMed
    Score: 0.646
  2. Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. Stroke. 2015 Jan; 46(1):229-36.
    View in: PubMed
    Score: 0.619
  3. Spreading depression and the clinical correlates of migraine. Rev Neurosci. 2013; 24(4):353-63.
    View in: PubMed
    Score: 0.543
  4. Pharmacological targeting of spreading depression in migraine. Expert Rev Neurother. 2012 Mar; 12(3):297-306.
    View in: PubMed
    Score: 0.512
  5. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation. 2012 Jan 17; 125(2):335-45.
    View in: PubMed
    Score: 0.504
  6. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci. 2011 Apr 13; 31(15):5755-63.
    View in: PubMed
    Score: 0.482
  7. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol. 2011 Feb; 69(2):413-8.
    View in: PubMed
    Score: 0.475
  8. Cortical spreading depression and migraine. Curr Neurol Neurosci Rep. 2010 May; 10(3):167-73.
    View in: PubMed
    Score: 0.451
  9. Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol. 2009 Oct; 66(4):564-8.
    View in: PubMed
    Score: 0.433
  10. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest. 2009 Jan; 119(1):99-109.
    View in: PubMed
    Score: 0.411
  11. Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization. J Headache Pain. 2020 Jul 06; 21(1):86.
    View in: PubMed
    Score: 0.228
  12. Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice. Neuroscience. 2019 09 01; 415:1-9.
    View in: PubMed
    Score: 0.213
  13. Caffeine does not affect susceptibility to cortical spreading depolarization in mice. J Cereb Blood Flow Metab. 2019 04; 39(4):740-750.
    View in: PubMed
    Score: 0.196
  14. Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation. Brain. 2017 Jun 01; 140(6):1643-1656.
    View in: PubMed
    Score: 0.184
  15. Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2016 Apr; 157(4):797-805.
    View in: PubMed
    Score: 0.170
  16. Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study. Neurology. 2015 Dec 01; 85(22):1945-9.
    View in: PubMed
    Score: 0.165
  17. Micro-heterogeneity of flow in a mouse model of chronic cerebral hypoperfusion revealed by longitudinal Doppler optical coherence tomography and angiography. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1552-60.
    View in: PubMed
    Score: 0.162
  18. Supply-demand mismatch transients in susceptible peri-infarct hot zones explain the origins of spreading injury depolarizations. Neuron. 2015 Mar 04; 85(5):1117-31.
    View in: PubMed
    Score: 0.158
  19. Migraine mutations impair hippocampal learning despite enhanced long-term potentiation. J Neurosci. 2015 Feb 25; 35(8):3397-402.
    View in: PubMed
    Score: 0.158
  20. Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One. 2013; 8(8):e71478.
    View in: PubMed
    Score: 0.141
  21. Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect. J Cereb Blood Flow Metab. 2013 Jun; 33(6):954-62.
    View in: PubMed
    Score: 0.138
  22. Glucose modulation of spreading depression susceptibility. J Cereb Blood Flow Metab. 2013 Feb; 33(2):191-5.
    View in: PubMed
    Score: 0.133
  23. Increased glucose availability does not restore prolonged spreading depression durations in hypotensive rats without brain injury. Exp Neurol. 2012 Dec; 238(2):130-2.
    View in: PubMed
    Score: 0.132
  24. Cortical spreading depression impairs oxygen delivery and metabolism in mice. J Cereb Blood Flow Metab. 2012 Feb; 32(2):376-86.
    View in: PubMed
    Score: 0.125
  25. Chronic daily cortical spreading depressions suppress spreading depression susceptibility. Cephalalgia. 2011 Dec; 31(16):1601-8.
    View in: PubMed
    Score: 0.125
  26. Gabapentin reduces infarct volume but does not suppress peri-infarct depolarizations. J Cereb Blood Flow Metab. 2011 Jul; 31(7):1578-82.
    View in: PubMed
    Score: 0.121
  27. Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents. Anesthesiology. 2015 Dec; 123(6):1337-49.
    View in: PubMed
    Score: 0.042
  28. Large arteriolar component of oxygen delivery implies a safe margin of oxygen supply to cerebral tissue. Nat Commun. 2014 Dec 08; 5:5734.
    View in: PubMed
    Score: 0.039
  29. Stress hormone corticosterone enhances susceptibility to cortical spreading depression in familial hemiplegic migraine type 1 mutant mice. Exp Neurol. 2015 Jan; 263:214-20.
    View in: PubMed
    Score: 0.039
  30. Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents. Anesthesiology. 2013 Aug; 119(2):317-25.
    View in: PubMed
    Score: 0.035
  31. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010 Feb; 67(2):221-9.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.